Menu
Recruiting NCT06367192

School Readiness Intervention for Preschool Children With Sickle Cell Disease

No phase Interventional Sickle Cell Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: The adapted Kids in Transition to School Intervention, Standard school resources.
Who it may be relevant to
Registry conditions: Sickle Cell Disease. Basic parameters: 42 months — 78 months · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The study participant is being asked to take part in this clinical trial, a type of research study, because the participant is a young child with sickle cell disease or the caregiver of a child with sickle cell disease. This study is being done to test a school readiness program for children with sickle cell disease (ages 3.5-6,5 years old). Primary Objective Assess feasibility and acceptability of an adapted school readiness intervention among preschool children (ages 3.5-6.5) diagnosed with sickle cell disease. Secondary Objectives Objective 1: Measure preliminary efficacy of the adapted school readiness intervention compared to routine care among preschool children ages (3.5-6.5) diagnosed with sickle cell disease. Objective 2: Examine implementation factors (i.e., barriers and facilitators) during post-intervention.

Detailed description

* Group randomization- Parent and child will be randomly selected (like the flip of a coin) to receive either the school readiness intervention or the standard school resources. * Attend virtual classroom program sessions- If the participant is in the school readiness group, the caregiver, will attend about 8 weeks of sessions virtually with a teacher and a caregiver of a child with sickle cell, for a total of 8 sessions. The sessions will be during the summer and done in a group. Each session will last about 1 ½ hours and will be video recorded. These sessions will be shared with another researcher for feedback and consistency. * Complete a caregiver interview-If you are in the school readiness group, a member of the study team will interview you after the virtual classroom sessions are over. The interview will take about 15-20 minutes and will be audio recorded. The caregiver will be asked for suggestions and how satisfied with the program. * Complete assessments - Caregiver and child will complete a set of assessments that evaluate school readiness skills (e.g., early math and reading), child behaviors, and parent-child relationships before and after the intervention.

Interventions

  • Behavioral The adapted Kids in Transition to School Intervention
    An intensive, school readiness intervention designed to improve preschoolers' social skills, early literacy, numeracy, and self-regulation skills at high risk for academic difficulties. The intervention is delivered virtually over 8 weeks with caregivers and intentionally occurs over the summer when there is a gap in preschool services.
  • Behavioral Standard school resources
    Information about local preschool programs and age appropriate books for children will be provided.

Primary outcome measures

  • Feasibility of Intervention Measure [Time frame: Collected immediately after the intervention]
  • Acceptability of Intervention Measure [Time frame: Collected immediately after the intervention]
Secondary outcome measures (6)
  • Bracken School Readiness Assessment - 3rd Edition [Time frame: Baseline and Collected immediately after the intervention]
  • Woodcock Johnson Tests of Achievement - Fourth Edition [Time frame: Baseline and Collected immediately after the intervention]
  • NIH Toolbox Flanker Test [Time frame: Baseline and Collected immediately after the intervention]
  • Head-Toes-Knees-Shoulders Revised [Time frame: Baseline and Collected immediately after the intervention]
  • Behavior Rating Inventory of Executive Functioning Preschool or Child [Time frame: Baseline and Collected immediately after the intervention]
  • The Parenting Scale [Time frame: Baseline and Collected immediately after the intervention]

Eligibility criteria

Inclusion criteria

  • Diagnosed with sickle cell disease of any genotype.
  • Enrolled on the institutional protocol: Sickle Cell Clinical Research Intervention Program (SCCRIP)
  • Age 3.5-6.5 years inclusive at the time of enrollment
  • English as the primary language
  • Research participant and one parent willing to participate and provide consent/assent according to institutional guidelines

Caregiver Participants

  • Have a child diagnosed with SCD of any genotype between the ages of 3.5-6.5 years and enrolled in SCCRIP
  • English as the primary language

Exclusion criteria

  • Do not have a child diagnosed with SCD of any genotype between the ages of 3.5-6.5 years and enrolled in SCCRIP
  • Non-English speakers

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • St. Jude Children's Research Hospital — Memphis

Publications

  • Heitzer AM, Kang E, Tamboli M, Brazley-Rodgers M, Kolb-Quinn A, Carroll Y, Conklin HM, King AA, Hankins JS, Pears K, Fernandez ME. Adapting a school readiness intervention for children with sickle cell disease: an intervention mapping for adaptation approach. Front Public Health. 2026 Jul 6;14:1862943. doi: 10.3389/fpubh.2026.1862943. eCollection 2026. PMID 42524380

Identifiers

NCT: NCT06367192 · SKITS2 · K23HL166697

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗